DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Sheel Biotech Limited — Outcome of Board Meeting

NSE 2 hrs ago·31 Aug 2026, 1:17 pm

Sheel Biotech

Sheel Biotech Limited has informed stock exchanges that its Board of Directors held a meeting on August 31, 2026. The company has not yet disclosed the specific agenda items or the outcome of these discussions.

For investors, this update is currently a neutral development. The lack of detailed information means there are no immediate market-moving catalysts to react to at this time. The stock's performance will likely remain steady until the company releases further details regarding the board's decisions.

Investors should wait for the official press release to understand the substance of the meeting. Until then, there is no new information to act upon.